First Time Loading...

Sinovac Biotech Ltd
NASDAQ:SVA

Watchlist Manager
Sinovac Biotech Ltd Logo
Sinovac Biotech Ltd
NASDAQ:SVA
Watchlist
Price: 6.47 USD Market Closed
Updated: May 2, 2024

Sinovac Biotech Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sinovac Biotech Ltd
Net Income (Common) Peer Comparison

Comparables:
6160
1801
603392
S
002252
300122

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Sinovac Biotech Ltd
NASDAQ:SVA
Net Income (Common)
$107.9m
CAGR 3-Years
39%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Net Income (Common)
-¥13.6B
CAGR 3-Years
-25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Net Income (Common)
-¥1B
CAGR 3-Years
-1%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Net Income (Common)
¥1.2B
CAGR 3-Years
23%
CAGR 5-Years
34%
CAGR 10-Years
N/A
S
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Net Income (Common)
¥2.1B
CAGR 3-Years
23%
CAGR 5-Years
N/A
CAGR 10-Years
24%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Net Income (Common)
¥8.5B
CAGR 3-Years
40%
CAGR 5-Years
47%
CAGR 10-Years
45%

See Also

What is Sinovac Biotech Ltd's Net Income (Common)?
Net Income (Common)
107.9m USD

Based on the financial report for Dec 31, 2022, Sinovac Biotech Ltd's Net Income (Common) amounts to 107.9m USD.

What is Sinovac Biotech Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
33%

Over the last year, the Net Income (Common) growth was -99%. The average annual Net Income (Common) growth rates for Sinovac Biotech Ltd have been 39% over the past three years , 33% over the past five years .